RHHBY ROCHE HOLDING AG
- 35.070
- +0.070+0.20%
- 35.070
- 0.0000.00%
ROCHE HOLDING AG News
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
RAPT Upgraded at H.C. Wainwright on China Licensing Deal
RAPT Rockets 180% on Licensing Deal, $150M Private Placement
Analysts Conflicted on These Healthcare Names: Verastem (VSTM), Roche Holding AG (OtherRHHVF) and Cabaletta Bio (CABA)
Health Care Down on Backlash Fears -- Health Care Roundup
Prothena Stock Gains 38% After Parkinson's Treatment Shows Potential Benefits
Roche's Prasinezumab Misses Goal in Parkinson's Disease Study
European Shares Fall as Fed Turns Hawkish on Rates Outlook
Here's Why VKTX Stock Plummeted 18% on Wednesday
Roche's Negative Parkinson Drug Results Don't Surprise -- Market Talk
Express News | Genentech's Prasinezumab Phase IIb Study Misses Primary Endpoint But Shows Potential In Early Parkinson's Disease
Roche Says Parkinson's Disease Drug Missed Main Goal of Phase 2b Trial
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Roche Gets CE Marking for Mass Spectrometry Tech
Roche Transforms Mass Spectrometry Diagnostics With Launch of Cobas Mass Spec Solution
Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com
Sangamo Surges 24% After Roche Ends Development of Hemophilia A Gene Therapy
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases
PepGen Stock Craters 35% on FDA Clinical Hold
Analysts Offer Insights on Healthcare Companies: Checkpoint Therapeutics (CKPT) and Roche Holding AG (OtherRHHVF)
No Data
